Cerebras Systems, a trailblazer in advancing generative AI, has recently unveiled a strategic collaboration with Mayo Clinic, establishing Mayo Clinic as its inaugural partner in the field of generative AI. This transformative partnership, disclosed at the JP Morgan Healthcare Conference in San Francisco, is actively producing innovative large language models (LLMs) tailored for medical applications.

By harnessing the vast longitudinal data repository of Mayo Clinic and the cutting-edge generative AI compute of Cerebras, the collaboration aims to expedite breakthrough insights for improved patient outcomes and diagnoses. Given that the healthcare sector accounts for 17% of the United States' GDP, this collaboration holds immense potential to revolutionize the human experience and enhance the well-being of citizens. Mayo Clinic's choice of Cerebras is grounded in the latter's established expertise in developing and training large-scale, domain-specific generative AI models, emphasizing a patient-centric approach to healthcare AI.

The initial result of this collaboration is a diagnostic model for Rheumatoid Arthritis (RA), integrating patient records, DNA data, and drug molecules to optimize therapeutic matching for RA patients. The collaborative efforts between Mayo Clinic and Cerebras aim to extend this model to address other disease states.

The development of large AI models necessitates substantial computing power, extensive datasets, and specialized AI knowledge. Cerebras addresses these requirements with its purpose-built CS-2, powered by the WSE-2, offering unparalleled AI compute, software, and expertise. Cerebras has a proven track record of efficiently creating high-quality, domain-specific generative AI models, showcasing significant advancements in medical and scientific computing, often achieving noteworthy improvements characterized as "100x."

Source: businesswire.com

 

 

 

Report Abuse